— Know what they know.
Not Investment Advice

FEMY NASDAQ

Femasys Inc.
1W: -16.1% 1M: -32.9% 3M: -49.0% YTD: -83.7% 1Y: -72.3% 3Y: -90.6% 5Y: -98.6%
$2.05
-0.05 (-2.38%)
 
Weekly Expected Move ±9.6%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 34 · $6.2M mcap · 2M float · 21.65% daily turnover · Short 24% of daily vol

Revenue Segmentation

By Geography

Income Trends

Revenue
$2M +52.0% ▲
5Y CAGR: +11.9%
Gross Profit
$1M +56.7% ▲
5Y CAGR: +9.0%
Operating Income
-$18M -22.6% ▼
Net Income
-$19M -32.1% ▼
EPS (Diluted)
$-0.84 +9.7% ▲
EBITDA
-$16M -24.0% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$1M$1M$1M$1M$2M
YoY Growth+11.7%+13.7%+2.2%-11.1%+52.0%
Cost of Revenue$307K$370K$442K$380K$545K
Gross Profit$731K$809K$764K$692K$1M
Gross Margin70.5%68.6%63.4%64.5%66.6%
R&D Expenses$4M$4M$6M$7M$8M
SG&A Expenses$3M$4M$6M$8M$10M
Operating Expenses$8M$9M$12M$15M$19M
Operating Income-$7M-$8M-$12M-$15M-$18M
Operating Margin-668.0%-706.7%-961.7%-1353.4%-1091.8%
Interest Expense$13K$19K$13K$165K$2M
Income Before Tax-$7M-$8M-$11M-$14M-$19M
Tax Expense$2K$4K$6K$4K$10K
Net Income-$7M-$8M-$11M-$14M-$19M
Net Margin-666.2%-639.0%-944.6%-1329.1%-1155.0%
EPS (Diluted)$-0.59$-0.64$-0.97$-0.93$-0.84
EBITDA-$6M-$7M-$10M-$13M-$16M
Shares Outstanding12M12M12M15M22M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms